What is Phio Pharmaceuticals Corp (PHIO) stock price today?

Phio Pharmaceuticals Corp (PHIO) currently trades at $1.22 per share. The stock has a market capitalization of $13.94M and a P/E ratio of —x.

Is PHIO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Phio Pharmaceuticals Corp has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -37.23.

Is Phio Pharmaceuticals Corp financially healthy?

Phio Pharmaceuticals Corp's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -37.23 places it in the distress.

PHIO

Phio Pharmaceuticals Corp

NASDAQ: PHIO · HEALTHCARE · BIOTECHNOLOGY

$1.22

+3.39% today

Updated 2026-04-30

Market cap

$13.94M

P/E ratio

—

P/S ratio

48.01x

EPS (TTM)

$-1.45

Dividend yield

—

52W range

$1 – $3

Volume

0.3M

Market cap

$13.94M

P/E ratio

—

P/S ratio

48.01x

EPS (TTM)

$-1.45

Dividend yield

—

52W range

$1 – $3

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-37.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$14.00

+1047.54%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -37.23 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-2.08M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-11.30M	$-10.83M	$-7.15M	$-8.70M	$-2.37M
EPS	—	—	—	—	$-1.45
Free cash flow	$-12.25M	$-10.75M	$-7.11M	$-7.99M	$-2.08M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PHIO	$13.94M	26	4.3	3.0	5.0	4.8	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Phio Pharmaceuticals Corp trades at $1.22. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -37.23, it sits in the distress.

Frequently asked questions

What is Phio Pharmaceuticals Corp's stock price?

Phio Pharmaceuticals Corp (PHIO) trades at $1.22.

Is Phio Pharmaceuticals Corp overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Phio Pharmaceuticals Corp (PHIO)?

The analyst target price is $14.00, representing +1047.5% upside from the current price of $1.22.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-37.23 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

phiopharma.com

Quick metrics

P/S ratio48.01x

ROE-70.00%

Beta0.81

50D MA$1.21

200D MA$1.61

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PHIO vs LLY →PHIO vs JNJ →PHIO vs ABBV →Stock screener →